-
Characterizing Cardiovascular Disease Patients in US Community Hospitals Using InsightsDB
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns, Healthcare Costs and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US using MarketScan® data
Mar 10, 2025, 14:00 PM -
What is the Role of Humans in a World of Artificial Intelligence: An Exploratory Economic Evaluation of Human-AI Collaboration in Diabetic Retinopathy Screening
Mar 10, 2025, 14:00 PM -
Factors Affecting Per Capita Costs in Subdistrict Health Promotion Hospitals (SHPH) After Transfer to Provincial Administrative Organizations (PAO): A Study of Allocation Models in Thailand
Mar 10, 2025, 14:00 PM -
Impact of Cardiovascular, Renal and Metabolic Comorbidities on Activity and Health-Related Quality of Life in Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada
Mar 10, 2025, 14:00 PM -
Adjusted Comparison of Amivantamab in Combination With Carboplatin Plus Pemetrexed From the PAPILLON Study Versus US Real-World Frontline Treatments in Patients With Advanced NSCLC Harboring EFGR Exon 20 Insertions
Mar 10, 2025, 14:00 PM -
Validation of Artificial Intelligence (AI) Tool to Identify PICO Questions for EU Joint Clinical Assessment (JCA)
Mar 10, 2025, 14:00 PM -
Predicted vs. Actual Drug Spending for Interferon-Free Direct-Acting Antiviral Therapies in Hepatitis C: A Case Study on Drug Spending Forecasts
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Mirvetuximab Soravtansine in FRa-Positive Platinum-Resistant Ovarian Cancer in Japan
Mar 10, 2025, 14:00 PM -
The Institute for Clinical and Economic Review’s Incorrect Use of Incremental Cost-Effectiveness Ratios
Mar 10, 2025, 14:00 PM -
Focus Group Evaluation of Criteria for the Value Assessment of Medication-Adherence Enhancing Interventions (MAEIs)
Mar 10, 2025, 14:00 PM -
EHR Trends in First-Time ADHD Diagnoses and Amphetamine Prescriptions Across Age Groups (2021-2024)
Mar 10, 2025, 14:00 PM -
Why It Is Still Important to Ensure the Price is Right: Updates to Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials
Mar 10, 2025, 14:00 PM -
Factors Influencing the Quality of Life of Stroke Survivors: Results of an Online Survey in the US
Mar 10, 2025, 14:00 PM -
Survival Outcomes of Chemotherapy and Radiotherapy among Non-Small Cell Lung Cancer Patients with Brain Metastases: A SEER-based Cohort Analysis
Mar 10, 2025, 14:00 PM -
Treatment Experience and Other Health and Social Characteristics Among Patients With Cancer From a Large US Population-Based Survey
Mar 10, 2025, 14:00 PM -
Association Between Event-Free/Distant Relapse-Free Survival and Overall Survival in Patients With Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer
Mar 10, 2025, 14:00 PM -
Disease and Economic Burden of Dengue in Colombia, 2018-2022
Mar 10, 2025, 14:00 PM -
Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes
Mar 10, 2025, 14:00 PM
